Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC

BACKGROUND: Clofarabine has been proved to have higher anti-leukemic myeloid activity compared to fludarabine, a drug extensively used as part of reduced intensity conditioning (RIC) for allogeneic stem cell transplantation (allo-SCT). RESULTS: Eighty-four patients were included. The majority of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Bourgeois, Amandine, Labopin, Myriam, Leclerc, Mathieu, de Latour, Régis Peffault, Bourhis, Jean-Henri, Ceballos, Patrice, Orvain, Corentin, Wallet, Hélène Labussière, Bilger, Karin, Blaise, Didier, Rubio, Marie-Thérese, Guillaume, Thierry, Mohty, Mohamad, Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290956/
https://www.ncbi.nlm.nih.gov/pubmed/30564300
http://dx.doi.org/10.18632/oncotarget.26391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290956/
https://www.ncbi.nlm.nih.gov/pubmed/30564300
http://dx.doi.org/10.18632/oncotarget.26391

Ejemplares similares